SPPIs own P2 trial-"up to" 87 patient cohorts will be used to gain accelerated approval. Who knows, they might need only 50 of the "up to' 87 pts but it is a multi trial site study which gives it more validity than just having it at one trial site (MDACC). The MDACC study data will be used for BTD though. It took MDACC 13 months to recruit 50 EGFR pts. How long is it going to take to recruit "up to" 87 pts for each cohort for SPPIs study that started last Sept? At the BOA-ML CC last week, we heard JT say that they already have 22 trial sites up and running and that enrollment is going "very very well". Hmmm, maybe we should add 'SPPI finished recruiting pts for their P2 NSCLC study' as a top catalyst for this year too.
If they are granted BTD do you have a price target for the SPPI?
No, I don't but posts 2181, 2182 and 2055 come to mind.
News 
Market Data 
Discover 
